Comparison of the number of patients needed to treat with abciximab, eptifibatide and tirofiban to prevent death or myocardial infarction

被引：0
|
作者：
Wilson, MG
Jamal, HH
Wischet, W
Reid, P
机构：
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3552
引用
收藏
页码：650 / 650
页数：1
相关论文
共 50 条
  • [41] Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention
    Kereiakes, DJ
    Broderick, TM
    Roth, EM
    Whang, D
    Shimshak, T
    Runyon, JP
    Hattemer, C
    Schneider, J
    Lacock, P
    Mueller, M
    Abbottsmith, CW
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (04) : 391 - 395
  • [42] Number Needed to Treat to Prevent Relapse and Disability Worsening Among Patients with Relapsing MS Treated with Teriflunomide or Cladribine
    Boster, Aaron
    Berkovich, Regina
    Kantor, Daniel
    Poole, Elizabeth
    Roesch, Nora
    Chavin, Jeffrey
    Guce, Maxneil
    Miller, Aaron
    NEUROLOGY, 2019, 92 (15)
  • [43] Open-label, sequential comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary intervention
    Schweiger, MJ
    Changezi, HU
    Naglieri-Prescod, D
    Cook, JR
    CLINICAL THERAPEUTICS, 2003, 25 (01) : 225 - 234
  • [44] Eptifibatide and abciximab are equivalent as adjunctive therapy for percutaneous coronary intervention in a large unselected population with ST elevation myocardial infarction.
    Raveendran, G
    Lennon, R
    Bell, M
    Bresnahan, J
    Gersh, B
    Holmes, D
    Mathew, V
    Singh, M
    Ting, H
    Rihal, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A) : 38E - 38E
  • [45] DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER: NUMBER NEEDED TO TREAT, NUMBER NEEDED TO HARM & LIKELIHOOD TO BE HELPED OR HARMED
    Chalet, Francois-Xavier
    Luyet, Pierre-Philippe
    Rabasa, Cristina
    Vaillant, Cedric
    Saskin, Paul
    Ahuja, Ajay
    Citrome, Leslie
    SLEEP, 2023, 46 : A155 - A155
  • [46] Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty
    Lee, CW
    Moon, DH
    Hong, MK
    Lee, JH
    Choi, SW
    Yang, HS
    Kim, JJ
    Park, SW
    Park, SJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (11) : 1243 - +
  • [47] A randomized comparison of patients’ understanding of number needed to treat and other common risk reduction formats
    Stacey L. Sheridan
    Michael P. Pignone
    Carmen L. Lewis
    Journal of General Internal Medicine, 2003, 18 : 884 - 892
  • [48] A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats
    Sheridan, SL
    Pignone, MP
    Lewis, CL
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (11) : 884 - 892
  • [49] Eptifibatide versus abciximab in primary PCI for acute ST elevation myocardial infarction. The randomized EVA-AMI Study
    Zeymer, Uwe
    Teiger, Emmanuel
    CIRCULATION, 2007, 116 (22) : 2628 - 2628
  • [50] Intracoronary application of abciximab in patients with ST-Elevation myocardial infarction
    Woehrle, Jochen
    Mayer, Christine
    Kochs, Matthias
    Hombach, Vinzenz
    Nusser, Thorsten
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A) : 169L - 169L
12345